Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 132, 138-145
Abstract
No abstract availableKeywords
Funding Information
- AKI
- NCI-NIH (R01CA154321)
This publication has 40 references indexed in Scilit:
- RETRACTED: Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibitionSurgery, 2012
- Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular deliveryBiomedical Microdevices, 2011
- Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycinInternational Journal of Pharmaceutics, 2011
- Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapyChinese Medicine, 2011
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- Size‐Dependent Endocytosis of NanoparticlesAdvanced Materials, 2009
- Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generationJournal of Drug Targeting, 2007
- Hydrotropic Polymeric Micelles for Enhanced Paclitaxel Solubility: In Vitro and In Vivo CharacterizationBiomacromolecules, 2006
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugsBiochemical and Biophysical Research Communications, 1975